EV/FCF Ratio: 24.15x
Is the EV/FCF ratio high or low?
The EV/FCF ratio of 24.15x is in line with its 3-year average of 25.53x, around the middle of its 3-year range (14.87x–40.38x).
As of Friday, June 26, 2026. 1.98% below its 12-month average of 24.64x.
KVUE EV/FCF Ratio Chart
KVUE Average EV/FCF Ratio Chart
KVUE Current vs Average EV/FCF Ratio Chart
KVUE EV/FCF Ratio Metrics
EV/FCF RATIO
24.15x
EV/FCF RATIO AVG TTM
24.64x
EV/FCF RATIO AVG 3Y
25.81x
EV/FCF RATIO AVG 5Y
N/A
EV/FCF RATIO AVG 10Y
N/A
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-1.98%
CURRENT VS 3Y AVG
-6.42%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
KVUE Competitors' EV/FCF Ratio
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kenvue Inc. (KVUE) | $36.40B | 24.15x | 24.64x | 25.81x | N/A |
| Archer-Daniels-Midland Company (ADM)vs › | $36.89B | 9.83x | 26.96x | 34.78x | 42.21x |
| Kimberly-Clark Corp (KMB)vs › | $35.88B | 16.51x | 18.64x | 19.34x | 24.27x |
| The Hershey Company (HSY)vs › | $35.84B | 18.71x | 22.53x | 25.78x | 27.30x |
| The Kroger Co. (KR)vs › | $35.62B | 20.39x | 28.17x | 26.42x | 25.79x |
| Sysco Corporation (SYY)vs › | $38.66B | 26.29x | 27.29x | 25.24x | 36.76x |
| The Estée Lauder Companies Inc. (EL)vs › | $29.48B | 27.98x | 41.81x | 37.62x | 47.02x |
| Kellanova (K)vs › | $29.03B | 58.70x | 43.15x | 31.90x | 28.71x |
| Keurig Dr Pepper Inc. (KDP)vs › | $44.25B | 43.74x | 36.09x | 47.05x | 39.17x |
| The Kraft Heinz Company (KHC)vs › | $27.83B | 11.54x | 13.56x | 19.35x | 20.62x |
Cash Flow Valuation Comparison
EV/FCF
24.1x
P/FCF
20.0x
FCF Yield
5.00%
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
- EV/FCF accounts for debt and cash through enterprise value
- P/FCF only considers equity value
- EV/FCF can be compared across companies with different debt levels
- Both measure how the market values cash generation
EV/FCF Ratio Formula & Definition
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
EV/FCF Ratio FAQ
- What is the EV/FCF ratio for Kenvue Inc. (KVUE)?
- The EV/FCF ratio for KVUE stock is 24.15x.
- Is Kenvue Inc.'s EV/FCF ratio high or low?
- The EV/FCF ratio of 24.15x is in line with its 3-year average of 25.53x, around the middle of its 3-year range (14.87x–40.38x).
- What is the TTM average EV/FCF ratio for Kenvue Inc. (KVUE)?
- The TTM average EV/FCF ratio for KVUE stock is 24.64x.
- What is the 3Y average EV/FCF ratio for Kenvue Inc. (KVUE)?
- The 3Y average EV/FCF ratio for KVUE stock is 25.81x.
KVUE EV/FCF Ratio History
| DATE | EV/FCF RATIO |
|---|---|
| 2026-06-25 | 24.15x |
| 2026-06-24 | 23.98x |
| 2026-06-23 | 23.57x |
| 2026-06-22 | 22.99x |
| 2026-06-18 | 23.27x |
| 2026-06-17 | 23.15x |
| 2026-06-16 | 23.59x |
| 2026-06-15 | 23.40x |
| 2026-06-12 | 23.29x |
| 2026-06-11 | 23.21x |
| 2026-06-10 | 23.19x |
| 2026-06-09 | 23.05x |
| 2026-06-08 | 22.66x |
| 2026-06-05 | 22.83x |
| 2026-06-04 | 21.96x |
| 2026-06-03 | 21.91x |
| 2026-06-02 | 22.42x |
| 2026-06-01 | 22.45x |
| 2026-05-29 | 22.38x |
| 2026-05-28 | 22.76x |
| 2026-05-27 | 22.81x |
| 2026-05-26 | 22.60x |
| 2026-05-22 | 22.64x |
| 2026-05-21 | 22.57x |
| 2026-05-20 | 22.42x |
| 2026-05-19 | 22.24x |
| 2026-05-18 | 22.27x |
| 2026-05-15 | 22.20x |
| 2026-05-14 | 22.28x |
| 2026-05-13 | 22.28x |
| 2026-05-12 | 22.58x |
| 2026-05-11 | 22.26x |
| 2026-05-08 | 22.71x |
| 2026-05-07 | 22.84x |
| 2026-05-06 | 24.05x |
| 2026-05-05 | 23.70x |
| 2026-05-04 | 23.46x |
| 2026-05-01 | 23.77x |
| 2026-04-30 | 23.88x |
| 2026-04-29 | 23.54x |
| 2026-04-28 | 23.89x |
| 2026-04-27 | 23.88x |
| 2026-04-24 | 23.83x |
| 2026-04-23 | 23.83x |
| 2026-04-22 | 23.63x |
| 2026-04-21 | 23.62x |
| 2026-04-20 | 23.93x |
| 2026-04-17 | 23.97x |
| 2026-04-16 | 23.80x |
| 2026-04-15 | 23.62x |
| 2026-04-14 | 23.71x |
| 2026-04-13 | 23.58x |
| 2026-04-10 | 23.68x |
| 2026-04-09 | 23.77x |
| 2026-04-08 | 23.67x |
| 2026-04-07 | 22.99x |
| 2026-04-06 | 23.62x |
| 2026-04-02 | 23.44x |
| 2026-04-01 | 23.71x |
| 2026-03-31 | 23.56x |
| 2026-03-30 | 23.56x |
| 2026-03-27 | 23.87x |
| 2026-03-26 | 23.92x |
| 2026-03-25 | 24.02x |
| 2026-03-24 | 23.90x |
| 2026-03-23 | 23.96x |
| 2026-03-20 | 23.73x |
| 2026-03-19 | 23.77x |
| 2026-03-18 | 23.86x |
| 2026-03-17 | 24.15x |
| 2026-03-16 | 24.08x |
| 2026-03-13 | 23.83x |
| 2026-03-12 | 23.72x |
| 2026-03-11 | 24.01x |
| 2026-03-10 | 24.36x |
| 2026-03-09 | 24.58x |
| 2026-03-06 | 24.84x |
| 2026-03-05 | 24.68x |
| 2026-03-04 | 24.61x |
| 2026-03-03 | 24.57x |
| 2026-03-02 | 25.40x |
| 2026-02-27 | 25.65x |
| 2026-02-26 | 25.52x |
| 2026-02-25 | 25.26x |
| 2026-02-24 | 25.53x |
| 2026-02-23 | 25.46x |
| 2026-02-20 | 25.21x |
| 2026-02-19 | 26.76x |
| 2026-02-18 | 27.01x |
| 2026-02-17 | 26.46x |
| 2026-02-13 | 26.80x |
| 2026-02-12 | 26.63x |
| 2026-02-11 | 26.62x |
| 2026-02-10 | 26.36x |
| 2026-02-09 | 26.19x |
| 2026-02-06 | 26.13x |
| 2026-02-05 | 26.06x |
| 2026-02-04 | 25.99x |
| 2026-02-03 | 25.50x |
| 2026-02-02 | 25.25x |
| 2026-01-30 | 25.28x |
| 2026-01-29 | 25.04x |
| 2026-01-28 | 25.21x |
| 2026-01-27 | 25.40x |
| 2026-01-26 | 25.56x |
| 2026-01-23 | 25.75x |
| 2026-01-22 | 25.69x |
| 2026-01-21 | 25.25x |
| 2026-01-20 | 25.50x |
| 2026-01-16 | 25.04x |
| 2026-01-15 | 25.11x |
| 2026-01-14 | 24.95x |
| 2026-01-13 | 24.82x |
| 2026-01-12 | 24.81x |
| 2026-01-09 | 24.61x |
| 2026-01-08 | 24.80x |
| 2026-01-07 | 24.50x |
| 2026-01-06 | 24.52x |
| 2026-01-05 | 24.60x |
| 2026-01-02 | 25.18x |
| 2025-12-31 | 25.10x |
| 2025-12-30 | 25.21x |
| 2025-12-29 | 25.03x |
| 2025-12-26 | 25.03x |
| 2025-12-24 | 25.05x |
| 2025-12-23 | 24.83x |
| 2025-12-22 | 24.82x |
| 2025-12-19 | 24.83x |
| 2025-12-18 | 24.93x |
| 2025-12-17 | 25.14x |
| 2025-12-16 | 25.10x |
| 2025-12-15 | 25.05x |
| 2025-12-12 | 25.20x |
| 2025-12-11 | 25.18x |
| 2025-12-10 | 25.18x |
| 2025-12-09 | 24.83x |
| 2025-12-08 | 24.53x |
| 2025-12-05 | 24.73x |
| 2025-12-04 | 24.80x |
| 2025-12-03 | 24.77x |
| 2025-12-02 | 24.64x |
| 2025-12-01 | 25.07x |
| 2025-11-28 | 25.22x |
| 2025-11-26 | 25.07x |
| 2025-11-25 | 24.84x |
| 2025-11-24 | 24.53x |
| 2025-11-21 | 24.39x |
| 2025-11-20 | 23.81x |
| 2025-11-19 | 23.71x |
| 2025-11-18 | 23.90x |
| 2025-11-17 | 23.92x |
| 2025-11-14 | 24.41x |
| 2025-11-13 | 24.54x |
| 2025-11-12 | 24.42x |
| 2025-11-11 | 24.48x |
| 2025-11-10 | 24.54x |
| 2025-11-07 | 24.67x |
| 2025-11-06 | 24.17x |
| 2025-11-05 | 23.90x |
| 2025-11-04 | 23.60x |
| 2025-11-03 | 23.80x |
| 2025-10-31 | 21.66x |
| 2025-10-30 | 21.50x |
| 2025-10-29 | 21.59x |
| 2025-10-28 | 21.82x |
| 2025-10-27 | 22.49x |
| 2025-10-24 | 22.40x |
| 2025-10-23 | 22.51x |
| 2025-10-22 | 22.62x |
| 2025-10-21 | 22.32x |
| 2025-10-20 | 22.35x |
| 2025-10-17 | 22.74x |
| 2025-10-16 | 21.35x |
| 2025-10-15 | 23.89x |
| 2025-10-14 | 23.76x |
| 2025-10-13 | 23.84x |
| 2025-10-10 | 24.35x |
| 2025-10-09 | 24.57x |
| 2025-10-08 | 23.67x |
| 2025-10-07 | 23.84x |
| 2025-10-06 | 23.21x |
| 2025-10-03 | 23.36x |
| 2025-10-02 | 23.26x |
| 2025-10-01 | 23.40x |
| 2025-09-30 | 23.85x |
| 2025-09-29 | 23.98x |
| 2025-09-26 | 24.08x |
| 2025-09-25 | 23.78x |
| 2025-09-24 | 24.59x |
| 2025-09-23 | 25.04x |
| 2025-09-22 | 24.72x |
| 2025-09-19 | 26.34x |
| 2025-09-18 | 26.06x |
| 2025-09-17 | 26.34x |
| 2025-09-16 | 26.09x |
| 2025-09-15 | 26.23x |
| 2025-09-12 | 27.11x |
| 2025-09-11 | 26.94x |
| 2025-09-10 | 26.49x |
| 2025-09-09 | 26.97x |
| 2025-09-08 | 26.45x |
| 2025-09-05 | 26.67x |
| 2025-09-04 | 28.94x |
| 2025-09-03 | 28.83x |
| 2025-09-02 | 29.22x |
| 2025-08-29 | 29.14x |
| 2025-08-28 | 28.94x |
| 2025-08-27 | 29.19x |
| 2025-08-26 | 29.23x |
| 2025-08-25 | 29.70x |
| 2025-08-22 | 30.20x |
| 2025-08-21 | 30.00x |
| 2025-08-20 | 30.22x |
| 2025-08-19 | 30.06x |
| 2025-08-18 | 29.60x |
| 2025-08-15 | 29.72x |
| 2025-08-14 | 29.55x |
| 2025-08-13 | 30.32x |
| 2025-08-12 | 30.54x |
| 2025-08-11 | 29.74x |
| 2025-08-08 | 29.88x |
| 2025-08-07 | 30.38x |
| 2025-08-06 | 33.84x |
| 2025-08-05 | 34.11x |
| 2025-08-04 | 34.82x |
| 2025-08-01 | 34.04x |
| 2025-07-31 | 33.84x |
| 2025-07-30 | 34.16x |
| 2025-07-29 | 34.81x |
| 2025-07-28 | 35.06x |
| 2025-07-25 | 35.70x |
| 2025-07-24 | 35.25x |
| 2025-07-23 | 35.30x |
| 2025-07-22 | 35.47x |
| 2025-07-21 | 34.76x |
| 2025-07-18 | 34.58x |
| 2025-07-17 | 34.38x |
| 2025-07-16 | 34.38x |
| 2025-07-15 | 33.77x |
| 2025-07-14 | 34.34x |
| 2025-07-11 | 33.71x |
| 2025-07-10 | 33.15x |
| 2025-07-09 | 32.94x |
| 2025-07-08 | 32.86x |
| 2025-07-07 | 33.12x |
| 2025-07-03 | 33.32x |
| 2025-07-02 | 33.12x |
| 2025-07-01 | 33.22x |
| 2025-06-30 | 33.16x |
| 2025-06-27 | 33.10x |
| 2025-06-26 | 33.40x |
| 2025-06-25 | 33.48x |
| 2025-06-24 | 33.51x |
| 2025-06-23 | 33.75x |
| 2025-06-20 | 33.77x |
| 2025-06-18 | 33.73x |
| 2025-06-17 | 33.84x |
| 2025-06-16 | 34.12x |
| 2025-06-13 | 33.85x |
| 2025-06-12 | 34.64x |
Showing the most recent 260 of 788 data points. The chart above shows the full history.
Related Metrics
About Kenvue Inc.
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- CEO
- Kirk L. Perry